Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp, Sugen IncfiledCriticalPharmacia Corp
Priority to CR7276ApriorityCriticalpatent/CR7276A/en
Publication of CR7276ApublicationCriticalpatent/CR7276A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
El presente invento se relaciona con metodos de tratamiento o prevencion de trastornos neoplasicos utilizando inhibidores de la tirosinquinasa en combinacion con inhibidores de la ciclooxigenasa, en particular inhibidores selectivos de la ciclooxigenasa-2.The present invention relates to methods of treatment or prevention of neoplastic disorders using tyrosine kinase inhibitors in combination with cyclooxygenase inhibitors, in particular selective inhibitors of cyclooxygenase-2.
CR7276A2004-02-242004-02-24
COMBINATION THERAPY FOR CANCER TREATMENT
CR7276A
(en)
Compounds derived from substituted pyridazine; hedgehog and smo signaling inhibitors; pharmaceutical composition; and use for the treatment of disorders or syndromes associated with hyperproliferative diseases.